MCM
GILD icon

Munder Capital Management’s Gilead Sciences GILD Stock Holding History

Munder Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$12.9M Sell
121,475
-12,615
-9% -$1.24M 0.1% 238
2014
Q2 		$11.1M Sell
134,090
-65
-0% -$5.06K 0.08% 246
2014
Q1 		$9.51M Buy
134,155
+42,265
+46% +$3.31M 0.07% 257
2013
Q4 		$6.9M Sell
91,890
-34,740
-27% -$2.42M 0.05% 277
2013
Q3 		$7.96M Sell
126,630
-41,655
-25% -$2.49M 0.06% 257
2013
Q2 		$8.63M Buy
+168,285
New +$8.77M 0.07% 251

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Munder Capital Management's GILD Position: Q3 2014 in Review

Munder Capital Management reduced its Gilead Sciences (GILD) stake by 9.4% in Q3 2014, selling an estimated $1.24M and leaving 121,475 shares worth $12.9M. The position accounts for 0.1% of the portfolio, ranked #238.

Munder Capital Management first reported a position in GILD in Q2 2013 and has held it in 6 quarters since. 1,326 funds tracked by Wall St. Rank hold GILD as of Q3 2014.

  • Munder Capital Management held 121,475 shares of Gilead Sciences worth $12.9M as of Q3 2014.
  • Munder Capital Management sold 12,615 Gilead Sciences shares in Q3 2014, an estimated $1.24M.
  • Gilead Sciences made up 0.1% of Munder Capital Management's portfolio in Q3 2014, its #238 holding.
  • Munder Capital Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 6 quarters since.
  • 1,326 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2014.

Based on Munder Capital Management's 13F filing for Q3 2014, filed 31 Oct 2014.